A smarter way to manage asthma with a combination of a long-acting ?2-agonist and inhaled corticosteroid
Author:
Publisher
Informa UK Limited
Subject
Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine
Reference70 articles.
1. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma
2. Short-acting β2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting β2-agonist or salmeterol/fluticasone propionate combination
3. Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma
4. Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids
5. Scientific rationale for using a single inhaler for asthma control
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 2022 Year in Review: Pediatric Asthma;Respiratory Care;2023-05-09
2. Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting β2-agonists: A systematic review;PLOS ONE;2023-04-20
3. Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD;Thorax;2023-02-01
4. Comparison of National and Global Asthma Management Guiding Documents;Respiratory Care;2022-12-24
5. SMART - is it practical in the United States?;Current Opinion in Pulmonary Medicine;2022-02-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3